Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn,...

* Reuters is not responsible for the content in this press release.

Wed Jun 10, 2009 10:39am EDT

Screening Programs to Drive European GI Videoscope Market Despite Economic
Downturn, According to Millennium Research Group

WALTHAM, Mass., June 10 /PRNewswire/ -- Millennium Research Group (MRG), the
global authority on medical technology market intelligence, finds that despite
the economic downturn, market growth in the European gastrointestinal (GI)
videoscope segment will be fueled by increased colorectal cancer (CRC)
screening programs in France, Germany, and the UK.  As detailed in the
recently released European Markets for GI Endoscopy Devices 2009 report, the
rise in screening initiatives will expand patient awareness of the disease
and, accordingly, grow GI videoscope procedure volumes through 2013. 

Several CRC and celiac disease screening programs are now in place throughout
Europe, heightening patient awareness of the importance of screening and
improving access to the associated procedures. France, Germany, and the UK
each have nationwide CRC screening initiatives, while regional initiatives
exist in Italy and Spain. Screening programs will continue to expand in Europe
over the next 5 years, in spite of the economic crisis, prompting a rise in
colonoscopy and esophagogastroduodenoscopy (EGD) procedure volumes.  Because
GI videoscopes are used in these procedures, the expansion of the screening
programs will fuel demand for GI videoscopes.

"The number of GI endoscopy procedures performed in Europe will experience
considerable growth through 2013 due to increasing patient and physician
demand for minimally invasive procedures," says Tiffanie Demone, Senior
Analyst at MRG.  "Minimally invasive procedures allow for rapid patient
recovery and short, if any, hospital stays. These procedures thus have several
advantages over open surgical procedures, including cost savings for health
care systems and improved quality of life for patients." 

MRG's European Markets for Gastrointestinal (GI) Endoscopy Devices 2009 now
includes more competitor coverage and country-specific insights than ever
before. The report provides detailed analysis of key industry competitors,
procedural trending, and revenue growth for the major GI endoscopy devices in
France, Germany, Italy, the UK, and Spain. For the first time, this report
includes a market analysis of enteral feeding giving sets, GI cytology
brushes, and biliary cytology brushes.  Additionally, the 2009 report includes
analysis of all segments of the Spanish GI endoscopy device market.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company
(www.DecisionResourcesInc.com), is the global authority on medical technology
market intelligence and the leading provider of strategic information to the
health care sector. The company provides specialized industry expertise
through multiclient market research, ongoing Marketrack(TM) projects, customer
loyalty tracking, facility-level procedure forecasting, and customized
solutions.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers
best-in-class, high-value information, and insights on important sectors of
the health care industry. Clients rely on this analysis and data to make
informed decisions. Please visit Decision Resources, Inc. at
www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be
trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com





SOURCE  Millennium Research Group

Amy Krohn of Millennium Research Group, +1-416-364-7776 ext. 101,
akrohn@mrg.net; or Elizabeth Marshall of Decision Resources Inc.,
+1-781-296-2563, emarshall@dresources.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.